Replies to post #99062 on Anavex Life Sciences Corp (AVXL)

[plexrec]

investor300...good post--thanks for the wake-up call

[A_Good_Day_2]

Why not?? One of the items you list is:

"Phase 2a – Updates on 104 week extension Alzheimer’s study"

That would be the 15-month data. And the only real reason many were expecting it was because the company had posted an abstract saying they were going to present it.

I don't really care that they changed their mind. The 104-week extension isn't critical to proving 2-73 has potential. They already completed the 2a trial. Then they extended it to a whole year and completed that with fabulous efficacy results (which wasn't a primary endpoint).

Now they're just continuing to collect more data. Going for extra credit sort of.

Need to get the 2/3 study going soon.

You have to believe that things are moving behind the scenes, because they darn sure aren't happening on stage!

[attilathehunt]

Presentation on website was after they pulled the abstract? Let's answer that question.

[ExtremelyBullishZig]

Read this one again...then read it again...and again...and keep reading until you get it:

Phase2a ***updates*** on 104 Extension Alzheimer's study.

That means updates on progress. We expected it because the company spread published an abstract that stated 15-month data and submitted it to the conference.

Since that hasn't happened yet, expect extension trial updates before PK data.